- Home
- RFIL vs HRTX Comparison
RFIL vs HRTX Comparison
Compare RFIL & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RFIL | HRTX |
|---|---|---|
| Founded | 1979 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.3M | 228.3M |
| IPO Year | 1996 | 2007 |
Fundamental Metrics
Financial Performance| Metric | RFIL | HRTX |
|---|---|---|
| Price | $18.75 | $0.40 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $11.25 | $4.50 |
| AVG Volume (30 Days) | 215.5K | ★ 3.8M |
| Earning Date | 06-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.59 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $55,325,000.00 | ★ $154,904,000.00 |
| Revenue This Year | $9.65 | $15.28 |
| Revenue Next Year | $6.40 | $20.29 |
| P/E Ratio | $1,203.00 | ★ N/A |
| Revenue Growth | ★ 10.22 | 7.36 |
| 52 Week Low | $4.08 | $0.39 |
| 52 Week High | $19.77 | $2.30 |
Technical Indicators
Market Signals| Indicator | RFIL | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 59.19 | 23.83 |
| Support Level | $6.31 | N/A |
| Resistance Level | $19.39 | $1.34 |
| Average True Range (ATR) | 1.53 | 0.06 |
| MACD | -0.15 | -0.03 |
| Stochastic Oscillator | 78.17 | 3.26 |
Price Performance
Historical ComparisonAbout RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company has one operating segment. The company operates in Canada, Germany, China, the USA, and the United Kingdom, and Others.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.